ParaPRO: Innovations in Life Sciences

ParaPRO Press Release

Date: August 18, 2009 Back
Contact: Roland Bydlon, Director of Marketing, 317-428-4597, rolandb@parapro.com

ParaPRO introduces Dr. Itchy™ to help school nurses and parents teach students about head lice.

Free Head Lice Educational Toolkit available at www.dritchy.com includes a Head Lice Educational Poster, Head Lice Pictures, an editable School Nurse Head Lice Notification Letter and “Is It Head Lice?” presentation with kid-friendly instruction to reduce the stigma of a head lice infestation.

Carmel, IN. - The mere thought of head lice is frightening to many parents, children, teachers and school administrators.  Head lice do not cause or carry disease.  The do not fly, jump or hop.  They spread primarily from head to head contact.  Any situation where children rub heads is a great place to spread head lice.

To help School Nurses and parents educate children about head lice, ParaPRO has developed a Head Lice Educational tool kit.  It can be accessed and downloaded free of charge at www.dritchy.com.

This Head Lice Educational Toolkits contains:

  • “Is It Head Lice?” Educational Poster with removable Magnifier
  • Editable “Is It Head Lice?” PowerPoint Presentation
  • Editable Head Lice Notification Letter for School Nurses
  • Head Lice Photo Gallery
  • Head Lice Flash Game (coming soon)
  • Dr. Itchy Head Lice Educational Cartoons (coming soon)

The American Academy of Pediatrics estimates that 6 to 12 million individuals have infestations each year.  Lice outbreaks are thought to account for 12-24 million lost school days per year with almost every school district in the country affected.

A search on the term “head lice” on Google will return over 1 million links” said Roland Bydlon, Director of Marketing at ParaPRO.  “ParaPRO has created a fictional character Dr. Itchy and a disease awareness web site www.dritchy.com to help health care professionals inform caregivers, parents, and children about head lice in an entertaining but educational way.  The web site does not recommend a particular product or therapy.  Our goal is that professionals and caregivers will go to Dr. Itchy first for reliable information about head lice and treatment options.”

More information can be found at www.dritchy.com or by calling toll free to 877-542-3639 (877-LICE-NEWS)

ParaPRO LLC was founded in 2002 when SePRO Corporation of Carmel, IN purchased the worldwide rights to develop and market Spinosad for the control of lice in human health from Eli Lilly and Company. The compound is currently in clinical trials at multiple sites across the United States. More information on ParaPRO can be found at www.parapro.com.

SePRO Corporation is recognized as an industry leader in providing the highest level of technical service to customers who operate in specialty markets of the USA. To learn more about SePRO Corporation, its products, services and technologies, call 1-800-419-7779 or visit the SePRO web site at www.sepro.com.




Ask your doctor if Natroba Topical Suspension is right for you or your child.

INDICATION
Natroba Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients four (4) years of age and older.

ADJUNCTIVE MEASURES
Natroba TM Topical Suspension should be used in the context of an overall lice management program:
  • Wash (in hot water) or dry clean all recently worn clothing, hats, used bedding and towels
  • Wash personal care items such as combs, brushes, and hair clips in hot water
A fine-toothed comb or special nit comb may be used to remove dead lice and nits.

IMPORTANT SAFETY INFORMATION
Natroba Topical Suspension contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants.

Most common adverse events were: application site redness (3%), redness and irritation of the eyes (2%) and application site irritation (1%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.